Dermigen has formal consulting agreements with a number of academic scientists with expertise in dermal and hepatic toxicology, oxidative stress/damage, as well as the carcinogenic potential of chemicals (e.g., pesticides, petroleum middle distillates and organic peroxides), electromagnetic fields and ultraviolet radiation.  The acknowledged expertise of Dermigen’s Scientific Advisory Board, assures that Dermigen can access biomedical science on its advancing edge.  Because of its access to biomedical expertise, Dermigen’s services have been called upon by industry and industry consortia to address toxicological problems that require innovative research approaches.  Once a particular toxicological problem is identified, Dermigen’s preferred mode of operation is to assemble a Scientific Advisory Panel, drawing from consultants with whom Dermigen has existing agreements and securing the services of other scientists who bring new and needed expertise.  Dermigen works with its consultants to develop experimental protocols, select appropriate commercial/academic laboratories for research performance, facilitate transfer of required technology, and evaluate research results.  Dermigen possesses the management capabilities required to coordinate the activities of its consultants, Study Directors at commercial or academic laboratories, and sponsor representative/s.  Dermigen’s contacts with academic researchers has facilitated biotechnology-related collaborations funded through Small Business Innovation Research and Technology Transfer (SBIR/STTR) Grant programs (see listing of SBIR/STTR grant support).  Dermigen also provides litigation support, including background/ position papers and expert testimony, in cases involving health effects related to alleged exposure to environmental agents.  Dermigen’s activities have resulted in a number of publications that attest to its breadth of expertise (see Dermigen Bibliography).